A Phase 1 Study of FIT-CD19-CAR-T Cells in R/R B-ALL

NCT07066397 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Lymphoblastic Leukemia

Interventions

BIOLOGICAL: ARM011
DRUG: Fludarabine
DRUG: Cyclophosphamide

Sponsor

TriArm Therapeutics (Taiwan) Limited